EP4037735
Lyfjaafhendingarbúnaður
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
29.9.2020EP published:
3.9.2025EP application number:
20792812.8
EPO information:
European Patent Register
Max expiry date:
28.9.2040Expiry date:
28.9.2026Next due date:
30.9.2026
Title in English:
DRUG DELIVERY DEVICELanguage of the patent:
English
Timeline
Today
29.9.2020EP application
3.9.2025EP Publication
28.9.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks CA 91320, US
Inventor
Name:
FINKELSTEIN, EmilAddress:
Thousand Oaks, CA 91320-1799, US
Name:
EILERTSEN, LarsAddress:
Thousand Oaks, CA 91320-1799, US
Name:
SORENSEN, MichaelAddress:
Thousand Oaks, CA 91320-1799, US
Name:
MADURO NORBO, TobiasAddress:
Thousand Oaks, CA 91320-1799, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962908504 PDate:
30.9.2019Country:
US
Number:
202062961048 PDate:
14.1.2020Country:
US
Classification
Categories:
A61M 5/28, A61M 5/315, A61M 5/20, A61M 5/32
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 8.10.2025
Expires: 28.9.2026
Payer: Árnason Faktor ehf.